We are live on ! Find out more
PCAP

Pratt Collard Advisory Partners Portfolio holdings

AUM $150M
1-Year Est. Return 51.02%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+51.02%
3 Year Est. Return
+91.71%
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
+$1.58M
Cap. Flow
-$4.19M
Cap. Flow %
-3.3%
Top 10 Hldgs %
37.83%
Holding
113
New
4
Increased
26
Reduced
50
Closed
8

Top Buys

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$388K
2
OVV icon
Ovintiv
OVV
+$269K
3
LIN icon
Linde
LIN
+$206K
4
BALL icon
Ball Corp
BALL
+$200K
5
DOV icon
Dover
DOV
+$195K

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$696K
2
PG icon
Procter & Gamble
PG
+$522K
3
BA icon
Boeing
BA
+$506K
4
IHE icon
iShares US Pharmaceuticals ETF
IHE
+$323K
5
AMZN icon
Amazon
AMZN
+$298K

Sector Composition

Rank Sector Weight
1 Technology 17.75%
2 Consumer Staples 17.66%
3 Healthcare 16.97%
4 Financials 13.96%
5 Communication Services 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
51
Dominion Energy
D
$61.3B
$707K 0.56%
9,150
-161
-2% -$12.3K
SBUX icon
52
Starbucks
SBUX
$121B
$707K 0.56%
8,439
-2,100
-20% -$165K
MA icon
53
Mastercard
MA
$510B
$706K 0.56%
2,670
+135
+5% +$33.8K
ADI icon
54
Analog Devices
ADI
$179B
$690K 0.54%
6,114
KO icon
55
Coca-Cola
KO
$381B
$678K 0.53%
13,314
-1,000
-7% -$49K
CYBR
56
DELISTED
CyberArk
CYBR
$665K 0.52%
5,200
NSC icon
57
Norfolk Southern
NSC
$75B
$638K 0.5%
3,202
CVS icon
58
CVS Health
CVS
$134B
$593K 0.47%
10,875
+1,980
+22% +$107K
ABMD
59
DELISTED
Abiomed Inc
ABMD
$573K 0.45%
2,200
ABBV icon
60
AbbVie
ABBV
$455B
$567K 0.45%
7,799
-209
-3% -$16.4K
CLX icon
61
Clorox
CLX
$11.7B
$537K 0.42%
3,507
XYL icon
62
Xylem
XYL
$27.3B
$520K 0.41%
6,220
+190
+3% +$15.1K
WAT icon
63
Waters Corp
WAT
$37.3B
$493K 0.39%
2,290
-50
-2% -$10.9K
TAP icon
64
Molson Coors Class B
TAP
$7.79B
$468K 0.37%
8,350
+3,260
+64% +$190K
WTRG icon
65
Essential Utilities
WTRG
$11.4B
$467K 0.37%
11,279
-200
-2% -$7.78K
OXY icon
66
Occidental Petroleum
OXY
$55.6B
$454K 0.36%
9,035
-190
-2% -$10.7K
GLD icon
67
SPDR Gold Trust
GLD
$133B
$448K 0.35%
3,360
KEY icon
68
KeyCorp
KEY
$24.2B
$445K 0.35%
25,058
-14,484
-37% -$245K
TEUM
69
DELISTED
Pareteum Corporation
TEUM
$440K 0.35%
168,682
-41,121
-20% -$163K
GD icon
70
General Dynamics
GD
$103B
$409K 0.32%
2,249
SLB icon
71
SLB Ltd
SLB
$72.6B
$401K 0.32%
10,099
+190
+2% +$7.66K
AVP
72
DELISTED
Avon Products, Inc.
AVP
$399K 0.31%
102,805
-23,200
-18% -$77.3K
HD icon
73
Home Depot
HD
$332B
$386K 0.3%
1,854
HON icon
74
Honeywell
HON
$76.7B
$384K 0.3%
2,334
BA icon
75
Boeing
BA
$175B
$375K 0.3%
1,030
-1,389
-57% -$506K

Similar funds

Pratt Collard Advisory Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Pratt Collard Advisory Partners held 113 positions worth $127M, up 1.3% from $125M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pratt Collard Advisory Partners withdrew a net $4.19M in Q2 2019, closing 8 positions and reducing 50 holdings. Its most notable exit was iShares US Pharmaceuticals ETF, an estimated $323K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Pratt Collard Advisory Partners opened a new position in Linde worth $221K.

  • Pratt Collard Advisory Partners's largest Q2 2019 buy was Linde: 1,099 shares worth $221K.
  • Pratt Collard Advisory Partners added most to M&T Bank in Q2 2019, an estimated $388K increase.
  • Pratt Collard Advisory Partners's biggest Q2 2019 reduction was Blackstone, cutting an estimated $696K.
  • Pratt Collard Advisory Partners fully exited iShares US Pharmaceuticals ETF in Q2 2019, selling an estimated $323K.
  • Pratt Collard Advisory Partners's ten largest holdings make up 38% of its $127M portfolio in Q2 2019.
  • Pratt Collard Advisory Partners opened 4 new positions and closed 8 in Q2 2019.
  • Pratt Collard Advisory Partners's portfolio value rose 1.3% quarter-over-quarter to $127M.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2019, filed 16 Jul 2019.